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Abstract
We studied the pattern of activation of stress kinases and of transcription factors activator protein-1 (AP-1) and heat
shock factor (HSF) in FAO cells by combining two treatments, i.e. heating (42‡C for 1 h) and proteasome inhibition, each
known to cause cellular heat shock response. The co-treatment heat shock (HS) and proteasome inhibitor (a peptidyl
aldehyde or lactacystin) showed cumulative effects on the intensity and duration of activation of c-Jun N-terminal kinase
(JNK) and p38 mitogen-activated protein kinase (MAPK) at the end of the HS period and during recovery. Similarly, the
thiol-reducing agents N-(2-mercaptoethyl)-1,3-diaminopropane and dithiothreitol strongly activated both JNK and p38
MAPK in cells undergoing HS. AP-1 DNA binding activity in response to proteasome inhibitors was so strong that it
shadowed the stimulatory effect of HS in the combined treatment, but lactacystin, which is the most potent and specific
proteasome inhibitor, decreased the binding late during recovery from HS. Thiol-reducing agents prevented AP-1 DNA
binding induced by HS. The combined HS/proteasome inhibitors or HS/thiol-reducing agents treatments cooperatively
activated HSF DNA binding. Expression of collagenase I and hsp 70 mRNAs reflects the different behavior of AP-1 and
HSF transcription factors in cells exposed to HS and proteasome inhibition. The data seem to indicate that JNK and p38
MAPK activations are not necessarily coupled to DNA binding of AP-1, which can be either increased or inhibited when
these kinases are activated. AP-1 and HSF show opposite patterns of response to HS in the presence of proteasome inhibitors
or reducing agents. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Exposure of cells to temperatures above their op-
timal growth temperature, i.e. heat shock (HS), or to
other metabolic stresses or toxic agents induces spe-
ci¢c genes encoding a group of proteins, the so-called
heat shock proteins (hsp). These proteins help the
cells to overcome the consequences of injury and
ensure survival. The synthesis of hsp is subjected to
di¡erent kinds of regulations, and although mRNA
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stability and translational control have been de-
scribed, the most signi¢cant e¡ect of HS is on tran-
scription. The induction of hsp mRNAs starts with
the activation of the heat shock transcription factor
(HSF), which binds to the consensus sequence heat
shock element (HSE), present in the promoter of HS
genes [1^4]. An induction of hsp72 is caused by pre-
vention of malfolded protein breakdown via the pro-
teasome, the major intracellular proteolytic system
[5].
Recently we have demonstrated that the integrity
of the intracellular polyamine pool, in particular an
adequate level of spermidine, is necessary for the
accumulation of hsp70 mRNA and for the DNA
binding of HSF induced by HS in cultured FAO
hepatoma cells [6,7]. In further experiments per-
formed on the liver of living rats subjected to
whole-body hyperthermia we have observed the acti-
vation of HSF as well as of other transcription fac-
tors, such as nuclear factor UB (NF-UB), activator
protein-1 (AP-1), and hypoxia-inducible factor-1
(HIF-1) [8]. However, in HS-exposed cells in vitro
only AP-1 is activated in addition to HSF, while
NF-UB and HIF-1 are not induced [7,9,10]. The ac-
tivation of AP-1 is impaired in spermidine-depleted
cells exposed to HS and may be reversed by addition
of exogenous spermidine [7]. Therefore only HSF
and AP-1 seem to be activated directly by HS.
AP-1 is a collective term referring to dimeric tran-
scription factors composed of Jun, Fos, and ATF
subunits that bind to the DNA sequences known as
the TPA response element (TRE) or cAMP response
element: activation of DNA binding might be ac-
companied by di¡erences in composition of the
dimers. Recent studies suggest that AP-1 complexes
with di¡erent composition may regulate the expres-
sion of di¡erent target genes, and perform distinct
biological functions. An involvement of AP-1 in
cell proliferation and survival, in£ammation, re-
sponse to stress, and sometimes cell death has been
reported [11].
The present study started with the evaluation of
the activity and protein levels of the stress-activated
protein kinases c-Jun N-terminal kinase (JNK) and
p38 mitogen-activated protein kinase (MAPK) in
FAO hepatoma cells exposed to HS and/or treated
with two di¡erent proteasome inhibitors or two dif-
ferent reducing agents. A role of phosphorylation in
the recruitment and activation of some of the sub-
units composing AP-1 has been suggested [11^13].
Targets of these kinases include JunD and ATF-2
[11,14], which here we demonstrate to be abundant
members of AP-1 activated by HS. Constituent sub-
units of some transcription factors are short-lived
proteins, subjected to ubiquitin-dependent degrada-
tion by proteasome [13,15], and the redox state of the
cell might also in£uence their phosphorylation and
degradation [14,16]. These considerations are the ra-
tionale for the present experiments dealing with the
e¡ects of proteasome inhibitors or of thiol-reducing
agents on HS-induced AP-1 DNA binding, JNK and
p38 MAPK activities as well as protein levels and
phosphorylation state of Jun family members. Fi-
nally, we examined the DNA binding activity of
HSF in response to the combinations of HS/protea-
some inhibitors or HS/reducing agents, and the ex-
pression of AP-1 and HSF target genes collagenase I
and hsp70.
It is known that proteasome inhibition stimulates
stress kinase activity and activates DNA binding of
all members of the HSF family [5,17^20]. The e¡ects
of the combination of proteasome inhibitors or of
reducing agents with HS are largely unknown.
Even if long-term treatment with a proteasome-spe-
ci¢c inhibitor prevents JNK-induced apoptosis in
cells exposed to HS (43‡C for 1 h), the role of tran-
scription factors AP-1 and HSF has not been clari-
¢ed under mild HS and short incubation with
proteasome inhibitors. The knowledge of the
interactions of these treatments may add useful in-
formation to unravel the puzzle of their alternative
and opposing pro- and anti-apoptotic e¡ects. These
experiments may represent a useful tool for the study
of the HS response and might have practical appli-
cations. Proteasome inhibitors may enhance survival
of cultured cells in otherwise toxic conditions or may
be medically useful in protecting tissues against is-
chemic injury or in organ maintenance before trans-
plantation [15].
2. Materials and methods
2.1. Materials
[Q-32P]ATP (3000 Ci/mmol), [K-32P]dCTP (3000 Ci/
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mmol), Hybond C-extra nylon ¢lters, Hybond ECL
nitrocellulose membranes and ECL chemilumines-
cence detection kit were purchased from Amer-
sham-Pharmacia (Amersham, Bucks., UK). Coon’s
F12 powder, horse serum and N-acetyl-L-leucinyl-L-
leucinal-L-norleucinal (LL) were from Sigma Chem-
ical Co. (St. Louis, MO, USA). clasto-Lactacystin L-
lactone (Lac) was from Calbiochem Co. (La Jolla,
CA, USA). N-(2-Mercaptoethyl)-1,3-diaminopro-
pane (WR 1065) was generously provided by Dr.
Jill Johnson, National Cancer Institute. JNK and
p38 MAPK activity assay kits were purchased from
New England Biolabs (Beverly, MA, USA). Oligonu-
cleotides for electrophoresis mobility shift assay
(EMSA) were synthesized by Primm (Milan, Italy).
Goat polyclonal antibodies against c-Jun (N) and c-
Fos (K25) (reactive with c-fos, FosB, Fra-1, and Fra-
2), mouse monoclonal antibody against p38 (A-12),
rabbit polyclonal IgGs against JNK1 (C-17), JunB
(N-17), JunD (329), and ATF-2 (C-19), and the
JunD blocking peptides were purchased from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA, USA). All
the other chemicals used were of the highest grade
available.
2.2. Cell cultures and treatments
The rat hepatocarcinoma cell line FAO (European
Collection of Cell Cultures, Salisbury, UK) was
cultured as previously reported [6]. Forty-eight
hours after plating, the £asks were heated by full
immersion in a water bath at 42‡C for 30 or
60 min. Then, some £asks were incubated for 60,
120, or 240 min at 37‡C to allow the cells to recover
from the immediate e¡ects of heating. In some ex-
periments the proteasome inhibitor LL (100 WM) or
Lac (10 WM), dissolved in dimethyl sulfoxide (0.4%),
was added 2 h before heating. The reducing com-
pound dithiothreitol (DTT; 2 mM) or WR 1065
(1 mM), dissolved in the culture medium, was added
1 h before HS.
2.3. JNK and p38 MAPK activity assays
The enzyme assays were performed as described by
the protocol of the manufacturer. The cells (10U106)
were lysed in 1 ml of lysis bu¡er containing 20 mM
Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton, 2.5 mM sodium pyrophosphate,
1 mM glycerophosphate, 1 mM Na3VO4, 1 mg/ml
leupeptin and 1 mM phenylmethylsulfonyl £uoride.
After JNK separation from 500 Wl of cell lysates
(corresponding to 500 Wg of protein) using 3 Wg of
GST^c-Jun (1^89) fusion protein beads, the kinase
reaction was performed in the presence of unlabelled
ATP (200 WM). Samples were separated by electro-
phoresis in 10% SDS^PAGE. After blotting, immu-
nodetection was carried out by incubation of the
membrane with phospho-speci¢c c-Jun antibody.
p38 MAPK activity was determined using 200 Wl
(corresponding to 200 Wg of protein) of the same
cell lysate, and the immunoprecipitation of the active
enzyme was performed with 20 Wl immobilized phos-
pho-p38 MAPK (Thr180/Tyr182) monoclonal anti-
body. The resulting immunoprecipitate was then in-
cubated with 3 Wg GST^ATF-2 (19^96) in the
presence of unlabelled ATP (200 WM). After gel elec-
trophoresis in 10% SDS^PAGE and blotting, immu-
nodetection was carried out by incubation of the
membrane with phospho-ATF-2 (Thr71) antibody,
which is the major ATF-2 phosphorylation site re-
quired for transcriptional activity. The immunoblots
were developed using ECL kit and were exposed to
X-ray ¢lms.
2.4. Western blot analysis of JNK1, p38 MAPK and
of Jun family members
Total cell proteins, prepared as reported above for
stress kinase assays, were fractionated by electropho-
resis on 10% SDS^PAGE, and incubated for 1 h with
1:1000 dilution of anti-JNK1 or anti-p38 MAPK
antibody (starting concentration 0.2 Wg/Wl). In some
experiments, total or nuclear cell proteins [21] were
fractionated by electrophoresis on 12% SDS^PAGE.
The blots were incubated for 1 h with a 1:2000 di-
lution of polyclonal anti-c-Jun, anti-JunB or anti-
JunD antibody (starting concentration 2 Wg/Wl).
When JunD blocking peptides were tested, 2 h pre-
incubation with 2.5-fold excess of peptides relative to
anti-JunD antibody (9 Wg) in 500 Wl of Tris-bu¡ered
saline was performed, and then the reaction mixture
was diluted to reach the usual antibody dilution.
After reaction with the suitable secondary antibody,
detection of the immunoblots was performed with
ECL kit and autoradiography.
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2.5. Analysis of the mobility of DNA^protein
complexes by gel electrophoresis (EMSA)
Nuclear extracts were prepared from 30U106 cells
(pool of three £asks) [22] and protein concentration
was determined by Bio-Rad assay with bovine serum
albumin as the standard. Equal amount of nuclear
protein (5 Wg) were subjected to EMSA using the
32P-labelled double-stranded sequence. For competi-
tion experiments, a 50-fold excess of speci¢c and
non-speci¢c unlabelled double-stranded sequences
was added to the binding mixtures. For supershift
experiments 5 Wg of nuclear extracts was incubated
with 1 Wl of antibodies (1 Wg/Wl) for 60 min on ice
without the oligonucleotide, followed by 20 min in-
cubation with the labelled oligonucleotide and then
electrophoresed [23].
The base sequences of the oligonucleotides used
were: HSE: CTAGAACGTTCTAGAAGCTTCGA-
G [24]; TRE: CTAGTGATGAGTCAGCCGGATC
[25]; oct-1 site: GATCGAATGCAAATCACTAG-
CT [26].
2.6. Northern blot analysis
Total cellular RNA was extracted by a single-step
method [6], and equal amounts (30 Wg) were electro-
phoresed on 0.8% agarose formaldehyde gel. To con-
¢rm that all lanes contained equal amounts of total
RNA, the ribosomal RNA concentration in each
lane was estimated visually in the ethidium bro-
mide-stained gels. The RNA was transferred to
nylon ¢lters by capillary blotting, and was hybridized
with the following speci¢c probes labelled by nick
translation (Amersham): the 750 bp PstI^SacI mur-
ine collagenase I (MMV-13) fragment (kindly pro-
vided by P. Angel, Deutsches Krebsforschungszen-
trum, Heidelberg, Germany), and the plasmid
containing the human pURHS70 cDNA for hsp70
(kindly provided by J.R. Nevins, New York, NY,
USA).
2.7. Densitometric analysis
All the autoradiograms were quanti¢ed by densi-
tometric analysis (OD per mm2) using an LKB Mas-
ter DTS system (Amersham-Pharmacia Biotechnol-
ogy).
2.8. Determination of polyamines
Extracts from cells treated with WR 1065 were
performed in 0.2 N HClO4, and polyamine analysis
by HPLC was carried out as previously described [6].
Protein content of supernatants used for HPLC anal-
ysis was determined by the method of Lowry et al.
[27].
3. Results
3.1. Patterns of activity and protein levels of JNK and
p38 MAPK after HS combined with proteasome
inhibitors
In the ¢rst group of experiments we determined
whether JNK and p38 MAPK activities were in-
creased by HS in FAO hepatoma cells. These kinases
are known to be activated by stressful conditions
[28,29], but no data have been reported for liver cul-
tured cells undergoing HS. Moreover, since very re-
cent studies show an enhanced MAPK activation
after proteasome inhibition [30], we also determined
the activity and protein levels of JNK and p38
MAPK in FAO cells pretreated with Lac, a very
speci¢c covalent inhibitor, and LL, a weaker non-
covalent inhibitor of proteasome [5,15]. The JNK
and p38 MAPK activities were measured using as
substrates GST^c-Jun and GST^ATF-2, respectively
(Fig. 1A). For JNK activity, we detected two bands
of phosphorylation of the fusion protein GST^c-Jun,
i.e. P1 and P2, which indicate the mono- and diphos-
phorylated forms, respectively, as found also in post-
ischemic reperfusion of the liver [31]. c-Jun-P2 is
phosphorylated at Ser residues 63 and 73. The pres-
ence of two bands with di¡erent degrees of phos-
phorylation could be a typical feature of liver or
liver-derived cell lines. When the cells were treated
for 120 min with proteasome inhibitors alone, a ¢ve-
fold enhancement of the P1 band with a very weak
e¡ect on the P2 band was observed, and the e¡ect
was similar at 180 min (data not shown). The degree
of increase is calculated relative to control values, i.e.
cells growing in medium containing 10% horse se-
rum. The addition of the vehicle alone (dimethyl
sulfoxide 0.4%) did not modify control values. The
P2 band became clearly detectable at the end of HS
BBAMCR 14723 23-1-01
L. Tacchini et al. / Biochimica et Biophysica Acta 1538 (2001) 76^89 79
(HS60) decreasing rapidly thereafter, while P1 in-
creased six-fold after heating (HS60) and remained
elevated during the period of recovery. In combina-
tion with HS, both the inhibitors further enhanced
JNK activity at the end of heating with an additive
e¡ect. Lac in particular seemed to prolong the time
of increase of JNK activity until R60. Since LL and
Lac do not appreciably increase the intensity of the
P2 band in normothermic cells their e¡ect during the
post-HS period seems to be a real potentiation of HS
rather than an activation due to the inhibitor. The
pattern of p38 MAPK activity was essentially similar
to that of JNK activity. Also GST^ATF-2 phosphor-
ylation was increased by the inhibitors of the protea-
Fig. 1. Regulation of stress kinases after HS combined with proteasome inhibitors. Control cells or cells pretreated with 100 WM LL
or 10 WM Lac were exposed to 42‡C for 1 h (HS60), and then left for 1 h (R60) or 2 h (R120) of recovery at 37‡C. (A) Time courses
of solid-phase kinase assays of GST^c-Jun (1^89) and GST^ATF-2 (19^96) fusion proteins, performed as reported in Section 2. Phos-
phorylated proteins were resolved on 10% SDS^PAGE gel. GST^c-Jun P1 : monophosphorylated band; GST^c-Jun P2 : diphosphory-
lated band. (B) Graphics representing the densitometric values (ODUmm2) of a typical experiment shown in A. hours: 0 = the begin-
ning of HS treatment; 1 = 1 h of HS; 2 = ¢rst hour of recovery; 3 = second hour of recovery. a, control; E, 2 h LL; O, 2 h Lac;
b, HS; F, HS/LL; R, HS/Lac. (C) Western blot analysis of stress kinase protein levels. Total cell extracts were prepared from treated
cells, and 40 Wg samples were analyzed as reported in Section 2. Hybridization of the membranes was performed with anti-JNK1 or
anti-p38 MAPK antibody, and the molecular mass of the corresponding bands is reported. All the experiments reported in the ¢gure
were performed in triplicate.
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some, and the stimulatory e¡ect was even more pro-
nounced when the cells were exposed to HS. The
densitometric values (ODUmm2) are reported in
the graphs (Fig. 1B). To evaluate whether the en-
zyme activities of stress kinases were correlated
with protein expression, we measured protein levels
by Western blotting and the results are reported in
Fig. 1C. JNK1 shows two bands (46 and 55 kDa),
which were not increased by proteasome inhibitors
alone or in combination with HS. However, addi-
tional bands between these two isoforms, probably
due to phosphorylation, appeared after HS60 as well
as when heating was performed in cells pretreated
with LL or Lac. These bands persisted during the
recovery period. The appearance of these bands
might be correlated with the increased activity of
the kinase. P38 MAPK protein level was never in-
creased but HS/Lac possibly showed a slight inhib-
itory e¡ect.
3.2. Patterns of JNK and p38 MAPK activity after
HS combined with reducing agents
We investigated the pattern of JNK and p38
MAPK in cells pretreated with the thiol-reducing
agents DTT and WR 1065 and then exposed to
HS. DTT readily permeates cell membranes and is
a protective reagent for sulfhydryl groups. It has
been reported that DTT may inhibit a second-stage
proteolytic process situated in the lumen of the en-
doplasmic reticulum and distinct from the LL-sensi-
tive pathway that occurs in the proteasome [32]. WR
1065 has been extensively studied for its ability to
protect cells from ionizing radiation [33]. The e⁄cacy
of low levels of the radioprotective aminothiols may
be due in part to their polyamine-like properties [34].
WR 1065 is a short-lived molecule rapidly converted
to WR 33278, and is known to modify cell poly-
amine homeostasis. Therefore, we measured the in-
Fig. 2. Regulation of stress kinases after HS combined with reducing agents. Control cells or cells pretreated with 1 mM WR 1065 or
2 mM DTT were exposed to 1 h HS (HS60), and then were left for 1 h (R60) or 2 h (R120) of recovery at 37‡C. (A) Kinase assays
were performed as reported in Fig. 1. GST^c-Jun P1 : monophosphorylated band; GST^c-Jun P2 : diphosphorylated band.
(B) Graphics representing the densitometric values (ODUmm2) of a typical experiment shown in A. hours: 0 = the beginning of HS
treatment; 1 = 1 h of HS; 2 = ¢rst hour of recovery; 3 = second hour of recovery. a, control ; E, 1 h DTT; O, 1 h WR 1065; b, HS;
F, HS/DTT; R, HS/WR 1065. All the experiments reported in the ¢gure were performed in triplicate.
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tracellular polyamine levels under HS conditions
after incubation with 1 mM WR 1065. We observed
that HS doubled the putrescine level relative to the
control value, which is 0.16 þ 0.02 nmol/mg of pro-
tein, and HS/WR 1065 treatment caused a further
2.4-fold increase. The levels of the other polyamines
were una¡ected (data not shown). These ¢ndings are
in agreement with the literature [33,34].
One hour treatment with each reducing agent ac-
tivated the two stress kinases examined (Fig. 2A),
and similar results were obtained in the following
2 h (data not shown), consistent with the literature
[35]. When compared with the value observed after
HS treatment, HS/WR 1065 increased JNK activity
at the end of HS and prolonged the activation of the
enzyme during the period of recovery by increasing
the P2 band (30-fold) as well as the P1 band (about
two-fold). In comparison with HS/WR 1065, HS/
DTT more strongly enhanced JNK activity at the
end of heating, but showed a lower post-heat shock
e¡ect on the P2 band. p38 MAPK seemed to be
regulated in a similar manner, and ATF-2 phosphor-
Fig. 3. DNA binding of AP-1 in cells undergoing HS in the presence of proteasome inhibitors (A) or reducing agents (B) and of oct-
1 in the same experimental conditions (C). EMSA analysis of nuclear extracts prepared from cells treated as reported in Figs. 1 and 2
and allowed to react with the TRE consensus sequence for AP-1 or oct-1. All the experiments reported in the ¢gure were repeated
three times.
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ylation was prolonged by both combined treatments.
The densitometric values (ODUmm2) are reported in
the graphs (Fig. 2B). In conclusion, the reducing
agents WR 1065 and DTT, which are able to activate
both JNK and p38 MAPK activities, can prolong the
e¡ect of HS on both kinases during the period that
follows the exposure to heat.
3.3. Regulation of AP-1 DNA binding activity
The time course of activation of AP-1 binding
caused by HS was as previously described [7]. The
two nuclear protein^DNA complexes for AP-1 were
increased by the proteasome inhibitors alone (Fig.
3A), i.e. the intensity of the slower band and the
faster band increased of about eight- and six-fold,
respectively. LL associated with HS did not appreci-
ably change the pattern observed after HS treatment.
The AP-1 binding activity returned to the control
value after 240 min of recovery from HS also in
the presence of LL (data not shown). Lac enhanced
AP-1 activity only during the ¢rst hour of HS treat-
ment, but caused a sudden drop of binding capacity
at R120. AP-1 DNA binding was only slightly in-
creased by both reducing agents in normothermic
cells (Fig. 3B). The increase in AP-1 activity during
the recovery period after HS seemed to be prevented
by pretreatment with WR 1065 or DTT, indicating a
role for pro-oxidant conditions in the activation. The
binding of the constitutive transcription factor oct-1
did not show appreciable changes by any of the
treatments tested (Fig. 3C). Competitions with unla-
belled oligonucleotide TRE or oct-1 demonstrated
the speci¢city of the binding (data not shown).
Fig. 4. Analysis of AP-1 composition. (A) Supershift of AP-1 was performed with 5 Wg of nuclear extracts from control cells (C),
from cells subjected to HS followed by 1 h of recovery (R60) or from cells exposed to 2 h Lac treatment. We used antibodies against
each member of the Jun family separately, or anti-c-Fos, which recognizes all the members of Fos family, or an antibody against the
ATF-2 subunit. Asterisks indicate supershifted complexes. (B) Western blot analysis of JunD. Cells were exposed to HS in the pres-
ence or absence of LL or Lac. Total and nuclear extracts were prepared at the end of HS and during recovery (R60 and R120), and
40 Wg protein samples were used for Western blot analysis, as reported in Section 2. Hybridization of the membranes was performed
with anti-JunD antibody, and the molecular mass of the corresponding bands is reported. The data shown are representative of three
experiments.
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We may conclude that LL and Lac strongly in-
crease AP-1 DNA binding in such a way as to shad-
ow the e¡ect of HS, but Lac seems to reduce the
period of activation of DNA binding after exposure
to heat.
3.4. Components of AP-1 after HS and proteasome
inhibition
Supershift assays were performed to identify the
components of AP-1 complexes in basal and acti-
vated conditions, i.e. 60 min of recovery or 120
min Lac treatment (Fig. 4A). We used antisera spe-
ci¢c for each member of the Jun family or ATF2,
and an antiserum that recognizes all the members of
the Fos family. Using nuclear extracts from control
cells, the slower complex appears to contain c-Jun
and JunD (supershift) and ATF-2 (immunodeple-
tion), while the faster complex contained JunD and
c-Fos (supershift). In R60 cells, the slower complex
appeared to contain c-Jun, JunD and c-Fos (super-
shift), JunB and ATF-2 (immunodepletion), while
the faster complex contained JunD and c-Fos (super-
shift). The AP-1 complexes activated by treatment
with Lac did not contain JunB, showing therefore
the same subunit composition as the control. These
data indicate that HS, besides increasing the DNA
binding, caused changes in composition of the acti-
vated AP-1 complexes that were shown to include
JunB.
To test whether the increased AP-1 binding activ-
ity was also in£uenced by the abundance of protein
components, we analyzed the levels of JunD, JunB
and c-Jun proteins in total and nuclear cell extracts
by Western blot. In agreement with the literature
[36], the anti-JunD antibody recognized two bands
of 41 and 46 kDa under basal conditions both in
total and in nuclear extracts (Fig. 4B). We focused
our attention on JunD 46 kDa. Using both protein
preparations, HS60 showed additional immunoreac-
tive bands with higher molecular masses correspond-
ing to elevated levels of phosphorylation. During re-
covery the intensity of these bands decreased (R60)
disappearing thereafter (R120).
In Western blot of total protein extracts, we ob-
served that the combined HS/LL or HS/Lac treat-
Fig. 5. DNA binding of HSF in cells undergoing HS in the presence of proteasome inhibitors (A) or reducing agents (B). Cells were
treated as reported in Figs. 1 and 2. EMSA analysis of nuclear extracts prepared from treated cells and allowed to react with HSE se-
quence. The experiments were performed in duplicate.
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ment enhanced the phosphorylation state observed at
the end of HS, and maintained it elevated during the
recovery period. The inhibitors per se (120 min treat-
ment) gave a certain stimulatory e¡ect. Using the
nuclear preparations, the combined HS/LL treatment
increased the intensity of the two phosphorylated
bands relative to HS60, while at R60 and R120 the
pattern of the bands was similar to that observed for
LL alone, i.e. a strong increase in JunD 46 kDa and
in a higher mass phosphorylated band. HS/Lac gave
the same e¡ect as HS alone, maintaining however a
slight phosphorylation state of JunD during the re-
covery period with a decrease of the JunD 46 kDa
protein level. The speci¢city of the immunoreactive
JunD bands after HS in the presence or absence of
LL or Lac treatment was demonstrated using speci¢c
competitor peptides, which prevented anti-JunD
antibody hybridization (data not shown). The JunB
protein level doubled during recovery from HS, while
the c-Jun protein level was una¡ected by the treat-
ments (data not shown).
We may summarize the data, and say that activa-
tion of AP-1 by HS is accompanied by changes in
subunit composition with prominent participation of
JunD and JunB, while AP-1 complexes activated by
Lac are essentially similar to that of the control. In
agreement with the results of gel supershift analysis,
JunD is the main subunit that shows changes in pro-
tein level and phosphorylation state.
3.5. Regulation of HSF DNA binding activity
The study was extended to HSF, whose activation
under normal temperature or HS conditions requires
di¡erent mechanisms including phosphorylations cat-
alyzed by MAPK(s) principally belonging to the
ERK class [37,38]. As reported in Fig. 5, we exam-
ined the e¡ect of combined proteasome inhibitors/HS
or reducing agents/HS treatment also on HSF DNA
binding, since these treatments interact to prolong
the activation of stress MAPKs (see Fig. 1). In agree-
ment with the literature [20], we observed an activa-
tion of HSF DNA binding by LL or Lac treatment.
LL and Lac reinforced HSF DNA binding after HS,
and gave a remarkable persistence of the binding
activity thereafter, which was more pronounced for
Lac (Fig. 5A). DTT or WR 1065 used alone did not
a¡ect the basal DNA binding of HSF. Under our
experimental conditions, the reducing agents did
not seem to interfere with the activation of HSF
induced by HS, but both seemed to prolong the
DNA binding during the recovery period (Fig. 5B).
Even if proteasome inhibitors activate HSF DNA
binding while reducing agents do not possess this
property, both treatments prolong the activation of
HSF DNA binding during the recovery period.
3.6. Northern blot analysis of the AP-1 and HSF
target genes collagenase I and hsp70
Since AP-1 contributes to transcriptional activa-
tion of matrix-degrading proteases, such as collage-
nase I [25,39], we analyzed the expression of this
gene after HS alone or in combination with Lac.
We chose to investigate Lac, which is the most spe-
ci¢c inhibitor of the proteasome. Under the same
experimental condition we also examined the expres-
sion of hsp70 to evaluate the functionality of the
HSF. It is known that the steady-state level of
mRNAs may increase some time after the activation
of the transcription factor: our investigation was,
therefore, extended to 240 min after the end of HS.
As reported in Fig. 6, the collagenase I mRNA level
was enhanced by Lac alone (240 min of treatment)
and during the recovery from heating (R240), and
these data are in agreement with the results of AP-1
Fig. 6. Northern blot analysis of (A) collagenase I and hsp70
mRNAs in cells treated with Lac (240 min), recovering from
HS (R60^R240) or subjected to HS/Lac combined treatment.
(B) Ribosomal RNAs.
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DNA binding (see Fig. 3). Moreover, the collage-
nase I mRNA expression was not enhanced by the
combined HS/Lac treatment, which caused an accel-
erated inactivation of AP-1 DNA binding activity.
Hybridization of the same blot with the hsp70 probe
showed that Lac treatment stabilized the steady-state
mRNA level during the recovery from HS. We may
conclude that activated HSF had a transactivation
e¡ect.
4. Discussion
Our investigation started with the analysis of the
patterns of JNK and p38 MAPK activities because
phosphorylations catalyzed by these kinases may be
associated with the activation of transcription factors
AP-1 and HSF. Phosphorylation is likely to reduce
ubiquitin-dependent degradation of AP-1 subunit(s)
by proteasome and to increase stabilization [12,13].
Proteasomes are associated with speci¢c and impor-
tant functions including degradation of various tran-
scription factors and short-lived regulatory proteins,
antigen processing, and angiogenesis [15]. Inhibition
of this proteolytic system increases the half-life of
ornithine decarboxylase, one of the shortest-lived
proteins, and elevates the intracellular level of the
polyamine putrescine [40].
We demonstrated that JNK and p38 MAPK activ-
ities were more induced after HS in the presence of
proteasome inhibitors than after the hyperthermic
stimulus alone. Enzyme activations were not associ-
ated with a corresponding increased protein level,
but at least for JNK1 with an enhanced phosphory-
lation state of the protein which is coherent with the
elevated activity. This is the ¢rst time that the activ-
ities of stress kinases have been shown to be en-
hanced by blocking the ubiquitin degradation system
of cells undergoing HS. Our results may also suggest
that after HS these stress kinases are rapidly down-
regulated by direct degradation or by changes of
unidenti¢ed intermediary molecules. Apparently
Lac, which is one of the most selective proteasome
inhibitors available, seemed more e⁄cient than LL,
which is a weaker non-covalent inhibitor acting on
calpain I [5,15]. Until now few and contradictory
data have been reported on JNK response to HS
treatment alone [28,41], which can depend on the
cell type and kind of hyperthermic treatment, while
proteasome inhibitors are known to activate stress
kinases [5,42].
The three di¡erent MAPK classes, i.e. Erk 1/2
(extracellular regulated kinases), JNK and p38
MAPK, appear to elicit distinct biological responses.
Erk 1/2 are predominantly activated by mitogens and
hormones, while JNK and p38 MAPK are activated
essentially by stress signals [43,44]. Even though the
immediate upstream triggers of JNK and p38 MAPK
are distinct, these two enzyme activities are stimu-
lated coordinately in most experimental systems
[45,46] including FAO cells exposed to the treatments
described in the present paper.
Additive e¡ects between inhibition of proteasome
and HS on AP-1 activity were not observed probably
because of the remarkable activation of AP-1 DNA
binding by LL and Lac. In contrast, additive e¡ects
of HS and proteasome inhibition were observed for
HSF activity. Our data support the idea that the
prolonged activation of stress kinases may result in
a persistent activation of HSF DNA binding. Since
under the same experimental conditions (HS/Lac),
AP-1 activity was rapidly down-regulated during re-
covery after heating, we suggest that the balance be-
tween activation of HSF and AP-1 might de¢ne the
fate of the cells. Proteasome inhibitors have been
reported to show both pro-apoptotic and anti-apo-
ptotic e¡ects [5] likely associated with concurrent ill-
de¢ned changes in the metabolic state of the cell. The
proteasome inhibitor-mediated activation of HSF, a
prerequisite for the synthesis of the protective hsp,
could explain why we did not observe signs of apo-
ptosis at either the morphological or the molecular
level in cells exposed to HS (42‡C for 1 h) as shown
in the present experiments and reported in the liter-
ature [5,6].
A further step in our investigation was the analysis
of the components of AP-1 transcription factor be-
cause the DNA binding activity and transactivation
potential are di¡erent for the various complexes of
AP-1 subunits [11]. We found that among the Jun
family members JunD and JunB were the main con-
stituents of AP-1 complexes activated after HS, and
were not so prominent after exposure to Lac. This is
in agreement with the suggestion that these two sub-
units play a role in cell response to stress [47]. We
also demonstrated that a high phosphorylation of
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JunD occurred after HS alone as well as after HS
combined with Lac, while the JunB protein level in-
creased after HS and c-Jun was una¡ected. In con-
trast to c-Jun, whose regulation by phosphorylation
is well documented [11,12], less is known about phos-
phorylation changes modulating the activity of
JunD. We suggest that also JunD phosphorylation
has a stabilizing e¡ect on the protein, and this might
be one of the reasons why a clear-cut enhancing ef-
fect of Lac on the activation of AP-1 binding due to
HS was not observed. JunD is known to be phos-
phorylated although less e⁄ciently that c-Jun, and
requires heterodimerization with c-Jun or JunB.
JunB does not seem to be phosphorylated by JNK
since it lacks a speci¢c proline residue £anking the
phosphoacceptor site [11]. Activation of AP-1 ob-
served after recovery from heating or prolonged
Lac treatment was functional as shown by the in-
crease of collagenase I expression. There was no col-
lagenase I expression when the combined treatments
decreased the duration of AP-1 activation.
Another new aspect of our work is the redox-de-
pendent regulation of JNK and p38 MAPK under
HS treatment. A mild increase in temperature (42‡C)
induces hsp and thermotolerance, with a possible in-
volvement of reactive oxygen species of still unde-
¢ned origin [48]. The mechanism of action of reduc-
ing agents on HSF binding activity is likely to be
indirect and seems to correlate with the enhancement
of MAPK activities. These enzymes may hyperphos-
phorylate HSF under stressful conditions such as
HS, activating the DNA binding. The reducing
agents decreased the AP-1 DNA binding capacity
in cells exposed to HS, even if DTT showed a slight
stimulatory e¡ect on AP-1 activity, as reported in the
literature [49]. Combining thiol-reducing agents with
exposure to heat may prevent intracellular oxidative
stress. The involvement of further mechanisms that
serve as a sensor for intracellular changes in redox
potential and might in£uence JNK activity, repre-
sented by the inhibitor glutathione S-transferase Pi,
cannot be excluded [50].
Under the condition of mild heating and short-
term proteasome inhibition the cell seems to main-
tain a physiological adaptive response with activa-
tion of HSF and of hsp70, which might prevent
cell death even if stress kinases are strongly acti-
vated.
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